TheranosticsPub Date : 2026-10-02eCollection Date: 2026-01-01DOI: 10.7150/thno.136769
Yijun Tao, Ting Liu, Yi Zhang, Hongyan Yue, Huaiyi Zhang, Ke Lin, Chenxi Wu, Yasi Huang, Xiaran Liu, Xiaoli Wang, Fei Fang, Yang Shen
{"title":"Advances in engineering organ-on-a-chip models of angiogenesis.","authors":"Yijun Tao, Ting Liu, Yi Zhang, Hongyan Yue, Huaiyi Zhang, Ke Lin, Chenxi Wu, Yasi Huang, Xiaran Liu, Xiaoli Wang, Fei Fang, Yang Shen","doi":"10.7150/thno.136769","DOIUrl":"https://doi.org/10.7150/thno.136769","url":null,"abstract":"<p><p>Angiogenesis plays a central role in embryonic development, tissue repair, tumor progression and cardiovascular remodeling. Because vascular growth involves a series of closely coordinated dynamic events, it is difficult for traditional <i>in vitro</i> and <i>in vivo</i> models to resolve the underlying mechanisms. Angiogenesis-on-a-chip (AoC) platforms provide microphysiological systems that can recapitulate key aspects of vascular growth <i>in vitro</i>, while enabling precise spatiotemporal control of the local microenvironment. These platforms combine microfluidic structures, three-dimensional hydrogels and relevant cell populations, so that biochemical gradients, mechanical cues and multicellular interactions can be regulated independently or in combination. When the relevant conditions are properly reproduced, endothelial sprouting, lumen formation and barrier function can be directly monitored and quantified. This review summarizes the recent progress of AoC design and discusses how these platforms can be used to study pathophysiological mechanisms, evaluate candidate therapeutic drugs and engineer vascularized tissues. The article also discusses persistent challenges, including platform standardization, characterization of the immune microenvironment, model validation and quantitative phenotypic analysis. By integrating engineering design with biological applications and an assessment of current limitations, this review provides a practical framework for advancing the application of AoC systems in vascular biology, therapeutic development and regenerative medicine.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9528-9556"},"PeriodicalIF":14.9,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684927/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
TheranosticsPub Date : 2026-10-02eCollection Date: 2026-01-01DOI: 10.7150/thno.140822
Haohao Zhang, Mengge Guo, Zhen Kong, Yujie Ma, Laixin Hong, Mingyuan Pang, Zimai Wang, Min Yang, Juan An, Yen Leng Pak, Jibin Song
{"title":"Bismuth-based nanosystems for precise tumor theranostics: Recent progress, challenges and perspectives.","authors":"Haohao Zhang, Mengge Guo, Zhen Kong, Yujie Ma, Laixin Hong, Mingyuan Pang, Zimai Wang, Min Yang, Juan An, Yen Leng Pak, Jibin Song","doi":"10.7150/thno.140822","DOIUrl":"10.7150/thno.140822","url":null,"abstract":"<p><p>Precision tumor diagnosis and treatment are constrained by inaccurate early diagnosis, therapeutic resistance, immunosuppressive tumor microenvironments, and toxic side effects of drugs, resulting in unsatisfactory efficacy of monotherapies. Multifunctional nanoplatforms capable of integrating multimodal imaging, synergistic therapy and immune regulation constitute a core research focus in precision oncology. Bi-based nanomaterials exhibit high X-ray attenuation, tunable band structures, excellent photoacoustic/catalytic performance and controllable degradability, rendering them suitable for imaging-guided precision tumor theranostics. This article systematically reviews four categories of Bi-based nanomaterials: elemental/single-phase, heterostructures, core-shell structures, and Bi-based/containing MOFs. We summarize strategies for structural modification and structure-activity relationship optimization, elaborate their advantages in multimodal imaging, as well as synergistic anti-tumor mechanisms combining phototherapy, radiotherapy, sonodynamic therapy and immunotherapy, including activation of regulated cell death, tumor microenvironment remodeling, and tumor growth inhibition and anti-metastasis effects. Furthermore, the bottlenecks hindering their clinical translation are outlined, and prospects for the development of precision nanotheranostics are proposed. This work provides theoretical references for the clinical translation of Bi-based nanomaterials for tumor theranostics.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9484-9527"},"PeriodicalIF":14.9,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149239698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
TheranosticsPub Date : 2026-09-28eCollection Date: 2026-01-01DOI: 10.7150/thno.138283
Chao Xing, Sibtain Muhammad, Bing Guo
{"title":"Harnessing ultrasound-responsive technologies for precision periodontitis therapy: a perspective.","authors":"Chao Xing, Sibtain Muhammad, Bing Guo","doi":"10.7150/thno.138283","DOIUrl":"https://doi.org/10.7150/thno.138283","url":null,"abstract":"<p><p>Periodontitis disease normally shows oxidative stress, immunological dysregulation, alteration of the periodontal bacterial ecology, and persistent alveolar bone loss. These mechanisms aggravate problems across the body in conjunction with causing tooth loss. The-state-of-the-art therapies using antimicrobial agents and mechanical debridement often fail to regulate immune signaling, clear infection, or repair tissue. Most recently, ultrasound-responsive materials have stood out to show advantages in restoring periodontal balance, which include two types (piezoelectric and sonodynamic materials). For sonodynamic materials, they generate reactive oxygen species (ROS) via acoustic cavitation, which degrades biofilms and disables microorganisms through oxidative damage. For piezoelectric materials, they convert mechanical stress into electrical polarization, resulting in surface charges that drive redox processes, affect immunological responses, and stimulate bone growth. Importantly, we highlight, to improve the periodontitis treatment outcomes, how these materials are incorporated into platforms such as injectable hydrogels, membranes, and scaffolds, which serve as carrier matrices for placing active medicines and improving spatiotemporal control. Also, we point out that integration of piezoelectric and sonodynamic technologies provides a way to combine antibacterial activity with regeneration stimuli. Moreover, challenges such as material stability, activation accuracy, and clinical translation are there and greater mechanistic understanding and rigorous design criteria are required for further development.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9434-9483"},"PeriodicalIF":14.9,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
TheranosticsPub Date : 2026-09-24eCollection Date: 2026-01-01DOI: 10.7150/thno.140697
Tehila Alter, Narmeen Haj, Doaa Ali-Naffaa, Maya Rom, Ramez Daniel, Galit Saar, Assaf A Gilad, Katrien Vandoorne
{"title":"A dual CEST-fluorescent reporter enables cross-validated tracking of hematopoietic engraftment in deep bone marrow.","authors":"Tehila Alter, Narmeen Haj, Doaa Ali-Naffaa, Maya Rom, Ramez Daniel, Galit Saar, Assaf A Gilad, Katrien Vandoorne","doi":"10.7150/thno.140697","DOIUrl":"https://doi.org/10.7150/thno.140697","url":null,"abstract":"<p><p>Reporter gene imaging can enable detection of engineered cells <i>in vivo</i>, but tracking hematopoietic engraftment within deep bone marrow (BM) remains challenging. We addressed this challenge by developing a dual CEST-MRI and fluorescent reporter system for cross-validated detection of reporter-positive donor-derived hematopoietic cells and their progeny in BM, with fluorescence-based assessment of HSPC-enriched compartments.</p><p><strong>Methods: </strong>A lentiviral dual-reporter cassette co-expressing the red fluorescent protein mScarlet-I (mScarlet) and the CEST-MRI reporter SuperCESTide (SC) via a T2A linker was evaluated in CT26 colon carcinoma cells <i>in vitro</i> and in a bilateral flank tumor model with contralateral reporter-transduced and non-transduced tumors in BALB/c mice (n = 6 tumors per group). <i>In vivo</i> optical imaging, CEST-MRI, <i>ex vivo</i> optical imaging, fluorescence microscopy, and histology were used for validation. The platform was then applied to primary murine hematopoietic lineage-negative (Lin⁻) cells and Lin⁻Sca-1⁺c-Kit⁺ (LSKs), with reporter expression analyzed by fluorescence microscopy and flow cytometry. Reporter-transduced Lin⁻ cells were transplanted into C57BL/6J mice after half-body irradiation, and engraftment was assessed 8 weeks later by whole-body fluorescence imaging, femoral CEST-MRI, intravital calvarial microscopy, <i>ex vivo</i> confocal microscopy, optical imaging, and flow cytometry. Femoral CEST-MRI was compared among non-irradiated controls, irradiated recipients transplanted with non-reporter-transduced Lin⁻ cells, and irradiated recipients transplanted with mScarlet-SC reporter-transduced Lin⁻ cells.</p><p><strong>Results: </strong>The dual mScarlet-SuperCESTide reporter showed efficient expression in CT26 cells and generated detectable red fluorescence and increased CEST-MRI contrast in reporter-positive tumors compared with contralateral non-transduced controls. <i>Ex vivo</i> optical imaging and histology confirmed reporter expression in tumor tissue. In murine BM-derived Lin⁻ cells, reporter expression was detected by fluorescence microscopy and flow cytometry, supporting feasibility in sensitive hematopoietic populations. Following transplantation, reporter-transduced Lin⁻ cells were detected eight weeks after engraftment using fluorescence imaging and femoral CEST-MRI. The recipients with reporter-transduced Lin⁻ cells showed increased femoral CEST contrast associated with the reporter compared with both irradiated recipients transplanted with non-transduced Lin⁻ cells and non-irradiated BM controls. Additionally, intravital microscopy visualized mScarlet⁺ cells within the BM niches of the calvarium. <i>Ex vivo</i> confocal microscopy and optical imaging confirmed reporter retention in BM, and flow cytometry confirmed mScarlet signal within Lin⁻ and LSK hematopoietic compartments in reporter-transduced recipients compared with non-transduced controls.</p><p><strong>Co","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9416-9433"},"PeriodicalIF":14.9,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
TheranosticsPub Date : 2026-09-24eCollection Date: 2026-01-01DOI: 10.7150/thno.136062
Xue Wu, Xiaorong Kou, Liping Bai, Chao Liu, Qinjie Wu, Ming Zhang, Ning Wang, Changyang Gong
{"title":"Recent advances in CRISPR technologies for biomedical applications and disease treatment.","authors":"Xue Wu, Xiaorong Kou, Liping Bai, Chao Liu, Qinjie Wu, Ming Zhang, Ning Wang, Changyang Gong","doi":"10.7150/thno.136062","DOIUrl":"https://doi.org/10.7150/thno.136062","url":null,"abstract":"<p><p>Clustered regularly interspaced short palindromic repeats (CRISPR), a precise genome-editing platform, has revolutionized genetic engineering. The highly selective and programmable characteristics of CRISPR have enabled its broad application. Recent advances in CRISPR biotechnology have promoted its widespread use in various biomedical fields, such as CRISPR screening. Ongoing preclinical and clinical trials will help determine the full capabilities of CRISPR in disease therapy. The efficacy of CRISPR-based applications is fundamentally dependent on optimized delivery strategies. Multiple approaches for delivering the CRISPR components have been investigated, primarily relying on physical, viral and non-viral delivery methods. Each method has specific strengths and limitations. Notably, non-viral delivery systems hold significant promise for CRISPR applications, offering distinct advantages such as transient expression, low immunogenicity, and fewer size constraints for cargo delivery. Various biomaterials demonstrate strong potential for delivering CRISPR components to achieve gene editing, including inorganic nanoparticles, polymeric nanoparticles, lipid nanoparticles, metal-organic frameworks, DNA origami, and virus-like particles. Therefore, this review provides an overview of recent research on the molecular principles of CRISPR and its biomedical applications. Recent advances in CRISPR-based treatments and their delivery vectors are also reviewed. Finally, the challenges faced by CRISPR technology are discussed.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9384-9415"},"PeriodicalIF":14.9,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684846/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Scalable manufacturing of human iPSC-derived functional liver organoids for acute liver failure treatment.","authors":"Xiaoshan Deng, Yunzhong Nie, Yoshihito Hayashi, Na Luo, Yang Li, Riana Plummer, Qinglin Li, Toshiharu Kasai, Takashi Okumura, Yu Kamishibahara, Takemasa Komoto, Takuya Ohkuma, Yasuhiro Yamada, Yumiko Isobe, Kiyoshi Yamaguchi, Satoshi Okamoto, Yasuharu Ueno, Naoki Tanimizu, Yoichi Furukawa, Hideki Taniguchi","doi":"10.7150/thno.137714","DOIUrl":"10.7150/thno.137714","url":null,"abstract":"<p><strong>Rationale: </strong>Acute liver failure (ALF) is a life-threatening disease associated with high mortality rates. Human induced pluripotent stem cell (hiPSC)-derived liver organoids (LOs) hold considerable promise as cell-based bridging therapies for ALF. However, the scalable production of highly consistent and mature LOs remains a major barrier to their clinical translation. In this study, we aimed to establish a scalable manufacturing platform for the reproducible generation of highly uniform and functionally mature liver organoids.</p><p><strong>Methods: </strong>We generated LOs from hiPSCs and established a differentiation platform designed for high-density LO production using low-attachment culture vessels combined with spin culture. The hepatic functions of conventionally cultured LOs (Con-LOs) and spin-cultured LOs (Spin-LOs) were evaluated using qPCR, albumin secretion assay, and detoxification assay. The molecular effects of spin culture on LO development were further analyzed using RNA sequencing. Furthermore, microwell bags were introduced to enhance manufacturing scalability. Finally, the LOs were transplanted into the intraperitoneal spaces of acetaminophen (APAP)-induced ALF mice to assess their therapeutic potential.</p><p><strong>Results: </strong>Compared to Con-LOs, Spin-LOs exhibited markedly elevated hepatic gene expression and significantly enhanced liver-specific functions. Mechanistically, spin culture enabled a metabolic transition from glycolysis to oxidative phosphorylation, thereby driving further functional maturation of liver organoids, resulting in improved synthetic, metabolic, and detoxification capacities. Moreover, integrating a microwell bag-based LO formation system with spin-culture-driven LO differentiation further promoted the efficiency and scalability of functional LO manufacturing. Importantly, these LOs provided short-term metabolic support following intraperitoneal transplantation into immunocompetent mice and significantly ameliorated APAP-induced liver failure.</p><p><strong>Conclusion: </strong>This study establishes a scalable manufacturing platform for the reproducible generation of highly uniform and functionally mature liver organoids. Our findings provide an evidence-supported foundation for their future clinical translation as cell-based bridging therapies for ALF.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9277-9294"},"PeriodicalIF":14.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149239641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
TheranosticsPub Date : 2026-09-18eCollection Date: 2026-01-01DOI: 10.7150/thno.129818
Jinli Li, Liyao Zhang, Yuanyuan Ren, Junxuan Wang, Pan Zhang, Qianran Shen, Yaqi Wang, Yi Yu, Zi Cheng, Qiang Wang, Haiying Wang, Yuyan Xiong
{"title":"ARG2 drives osteoblast senescence by repressing mitophagy via the IκB-NF-κB-TXN2 signaling axis: implications for age-associated osteoporosis.","authors":"Jinli Li, Liyao Zhang, Yuanyuan Ren, Junxuan Wang, Pan Zhang, Qianran Shen, Yaqi Wang, Yi Yu, Zi Cheng, Qiang Wang, Haiying Wang, Yuyan Xiong","doi":"10.7150/thno.129818","DOIUrl":"https://doi.org/10.7150/thno.129818","url":null,"abstract":"<p><strong>Rationale: </strong>Age-associated osteoporosis (AAOP) is characterized by progressive bone loss that can be driven by impaired osteoblast function and increased cellular senescence. However, the molecular mechanisms driving osteoblast senescence during aging remain incompletely understood. In this study, we aim to investigate the role of arginase 2 (ARG2) and its underlying mechanisms in osteoblast senescence and AAOP.</p><p><strong>Methods: </strong>AAOP were assessed in D-galactose-induced aging mice, naturally aged mice, and osteoblast-specific ARG2 knockout mice. <i>In vitro</i>, osteoblast senescence was induced by hydrogen peroxide exposure. Bone phenotypes, cellular senescence, mitochondrial function, and mitophagy were examined using histological, molecular, and imaging techniques. Luciferase reporter assays, co-immunoprecipitation (Co-IP), and pharmacological or genetic approaches were employed for molecular mechanistic investigations.</p><p><strong>Results: </strong>We observed that ARG2 expression was markedly elevated in senescent osteoblasts and aged mice with osteoporosis. Osteoblast-specific deletion of ARG2 alleviated age-related bone loss, improved trabecular bone microarchitecture, and reduced osteoblast senescence <i>in vivo</i>. Mechanistically, ARG2 promoted mitochondrial oxidative stress and impaired mitophagy, as evidenced by inhibition of the PINK1/Parkin/LC3 pathway and accumulation of p62. Furthermore, we revealed that ARG2 activated IκBα/NF-κB signaling, leading to HDAC9-mediated transcriptional repression of thioredoxin 2 (TXN2), a key mitochondrial antioxidant. Restoration of TXN2 expression, antioxidant treatment, or blockade of NF-κB/HDAC9 signaling rescued mitophagy, attenuated osteoblast senescence, and restored osteogenic function. Moreover, pharmacological inhibition of ARG2 using S-(2-boronoethyl)-L-cysteine (BEC) significantly suppressed osteoblast senescence and protected against age-related osteoporosis.</p><p><strong>Conclusion: </strong>ARG2 plays a pivotal role in osteoblast senescence and the development of AAOP by inducing mitochondrial oxidative stress and mitophagy dysfunction through the IκBα/NF-κB/HDAC9/TXN2 signaling axis. Targeting ARG2 may offer a promising therapeutic approach for AAOP prevention and treatment.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9295-9321"},"PeriodicalIF":14.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Organelle-targeted precision cancer theranostics: From molecular design to NIR-II imaging.","authors":"Dandan Chen, Beiling Zheng, Zhixiang Lu, Yaohui He, Pengfei Lyu","doi":"10.7150/thno.137525","DOIUrl":"https://doi.org/10.7150/thno.137525","url":null,"abstract":"<p><p>The disruption of organelle homeostasis is a hallmark in the process of tumor occurrence and development. The abnormalities of these subcellular structures not only indicate the pathological state of the body tissue, but also provide actionable targets for clinical intervention. In recent years, organelle targeted fluorescence imaging technology has shown unique advantages in tumor identification, subcellular localization and dynamic function monitoring. In this review, we systematically summarize the latest progress of organelle-targeted theranostics platforms for precise cancer diagnosis and treatment, focusing on five major organelles: Mitochondria (Mt), Lysosomes, Endoplasmic reticulum (ER), Nucleus and Golgi apparatus (GA). We discussed the molecular design strategies for these platforms to achieve targeted organelle diagnosis imaging. At the same time, we focused on comparing the activation mechanism of targeting motifs, imaging platforms, and advanced strategies such as Aggregation-Induced Emission (AIE), ratiometric imaging and signal amplification. These common strategies jointly ienhance the accuracy of tumor diagnosis. In addition, this review explores how organelle imaging information has evolved from a simple localization imaging tool to the basis for tumor treatment decision-making, including determining the best treatment window, regulating probe activation, monitoring intracellular transport, evaluating organelle damage, multi-organelle cascade therapies, and promoting immunogenic cell death. In addition to these cellular strategies, the emergence of Near-infrared II (NIR-II) fluorescence imaging provides the latest and key technical advantages for deep tissue tracking of biological distribution, tumor retention and treatment timing <i>in vivo</i>. This review aims to overcome the technical challenges of insufficient tissue penetration depth and insufficient targeted specificity in the field of tumor diagnosis and treatment, so as to promote the development of high-efficiency, low-toxic and accurate tumor platforms and accelerate their clinical translation.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9346-9383"},"PeriodicalIF":14.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
TheranosticsPub Date : 2026-09-18eCollection Date: 2026-01-01DOI: 10.7150/thno.135691
Jian Yu, Lujiao Yu, Fei Ren, Kai Cui, Gongping Sun, Hong Pan
{"title":"Hybrid exosome-liposome nanovesicles as delivery platforms for therapeutic applications: merging the best of both worlds.","authors":"Jian Yu, Lujiao Yu, Fei Ren, Kai Cui, Gongping Sun, Hong Pan","doi":"10.7150/thno.135691","DOIUrl":"10.7150/thno.135691","url":null,"abstract":"<p><p>Exosomes are increasingly employed to treat various diseases because of their remarkable ability to enhance the stability of encapsulated cargoes. This capability is attributed to their outstanding homologous targeting, desirable biocompatibility, and low immunogenicity, thereby contributing to improved therapeutic outcomes. Nevertheless, exosomes are constrained by some limitations, including poor loading capacity, inherent heterogeneity, and challenges in large-scale production. Consequently, hybrid exosome-liposome (EL) systems, which can circumvent these limitations, are playing an increasingly crucial role in therapeutic applications. Herein, we introduce the two primary strategies for drug loading into exosomes -- passive loading and active loading. We further elaborate on the fabrication methods of hybrid ELs and their applications in drug delivery, highlighting the innate advantages of these state-of-the-art nanovesicles over conventional exosomes and liposomes. Major challenges and future perspectives of hybrid ELs in treating various diseases are also discussed.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9261-9276"},"PeriodicalIF":14.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684820/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149239687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
TheranosticsPub Date : 2026-09-18eCollection Date: 2026-01-01DOI: 10.7150/thno.131051
Elisa Gonçalves de Andrade, Jared VanderZwaag, Rikke Hahn Kofoed, Katherine Picard, Keelin Henderson Pekarik, Micaël Carrier, Fernando González Ibáñez, Mohammadparsa Khakpour, Kullervo Hynynen, Isabelle Aubert, Marie-Ève Tremblay
{"title":"Early micro- and nanoscale microglial responses to blood-brain barrier modulation by transcranial focused ultrasound.","authors":"Elisa Gonçalves de Andrade, Jared VanderZwaag, Rikke Hahn Kofoed, Katherine Picard, Keelin Henderson Pekarik, Micaël Carrier, Fernando González Ibáñez, Mohammadparsa Khakpour, Kullervo Hynynen, Isabelle Aubert, Marie-Ève Tremblay","doi":"10.7150/thno.131051","DOIUrl":"https://doi.org/10.7150/thno.131051","url":null,"abstract":"<p><p>Modulation of the blood-brain barrier (BBB) using transcranial focused ultrasound with intravenous microbubbles (FUS) has progressed to clinical trials. Guided by magnetic resonance imaging (MRI), FUS significantly increases local BBB permeability for approximately 6-24 h in mice, with an ensuing mild inflammation. Microglia, as the immune cells of the brain, are stimulated by FUS-BBB modulation, although the timing and nature of their responses remain unclear. In this study, we characterized the cellular (i.e., density, distribution, and morphology) and subcellular (i.e., ultrastructure) microglial alterations early after FUS-BBB modulation.</p><p><strong>Methods: </strong>We targeted the hippocampi of adult, male mice with MRI-guided FUS in the presence of intravenous microbubbles. At 1 h and 24 h after FUS-BBB modulation, we investigated i) the density and distribution of ionized calcium-binding adaptor molecule 1 (Iba1)-positive (<sup>+</sup>) microglia; ii) the morphology of Iba1<sup>+</sup> soma and processes; and iii) the microglial organelles and contacts using scanning electron microscopy.</p><p><strong>Results: </strong>Microglial density and distribution were unchanged at 1 h and 24 h. However, FUS-BBB modulation was associated with elongated microglial cell bodies at both time points. At 1 h, microglia shifted to compact shapes with stubby processes, whereas at 24 h, they were larger, with fewer processes. At the nanoscale, microglia preserved interactions with blood vessels, but they increased their contacts with swollen astrocytic endfeet at 1 h and 24 h. By 24 h after FUS-BBB, microglia contacted pre-synaptic elements and extracellular space pockets less frequently, with ultrastructural indications of changes in metabolic demand and lysosomal activity.</p><p><strong>Conclusion: </strong>At 1 h and 24 h after FUS-BBB, traits of microglial surveillance were maintained, despite a shift in morphology associated with injury shielding in a subset of cells. FUS-BBB modulation appears to temporarily modify lysosomal, but not phagocytic properties, of microglia and to reduce ultrastructural indications of pre-synaptic remodeling early after treatment.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"16 16","pages":"9322-9345"},"PeriodicalIF":14.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13684825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}